MASQ: A multiplex qPCR platform for quantitative alternative splicing analysis in clinical specimens

< 0.0001). MASQ represents a broadly applicable platform for alternative splicing analysis, enabling applications including biomarker discovery, diagnostic development, and monitoring.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2026-04-01
DOI
https://doi.org/10.1016/j.omtn.2026.102923
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MASQ: A multiplex qPCR platform for quantitative alternative splicing analysis in clinical specimens

Kee Kwang Kim, Heon Yoo, Jong‐Il Park, Hyejeong Jeong et al.
Molecular Therapy — Nucleic Acids
RNA Research and Splicing
article

MASQ: A multiplex qPCR platform for quantitative alternative splicing analysis in clinical specimens

Kee Kwang Kim, Heon Yoo, Jong‐Il Park, Hyejeong Jeong, Namjoon Cho
article en

Abstract

< 0.0001). MASQ represents a broadly applicable platform for alternative splicing analysis, enabling applications including biomarker discovery, diagnostic development, and monitoring.

Molecular Therapy — Nucleic AcidsVol. 37(2)
Chungnam National University (KR)
National Research Foundation, National Research Foundation of Korea, Commercializations Promotion Agency for R and D Outcomes
Openalex Percentile: Top 35%
RNA Research and Splicing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.